Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Integer Holdings Corporation (ITGR : NYSE)
 
 • Company Description   
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.

Number of Employees: 11,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $126.50 Daily Weekly Monthly
20 Day Moving Average: 798,242 shares
Shares Outstanding: 33.99 (millions)
Market Capitalization: $4,299.99 (millions)
Beta: 0.62
52 Week High: $126.80
52 Week Low: $62.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.14% 1.59%
12 Week 39.24% 36.28%
Year To Date 61.29% 43.05%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5830 Granite Parkway Suite 1150
-
Plano,TX 75024
USA		 ph: 214-618-5243
fax: 716-759-5654		 ir@integer.net http://www.integer.net
 
 • General Corporate Information   
Officers
Payman Khales - Chief Executive Officer;President and Director
Pamela G. Bailey - Chair of the Board
Diron Smith - Executive Vice President and Chief Financial Offic
Tom P. Thomas - Vice President; Corporate Controller
Sheila Antrum - Director

Peer Information
Integer Holdings Corporation (ABMD)
Integer Holdings Corporation (DMDS)
Integer Holdings Corporation (CPWY.)
Integer Holdings Corporation (EQUR)
Integer Holdings Corporation (ECIA)
Integer Holdings Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45826H109
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 10/22/26
Share - Related Items
Shares Outstanding: 33.99
Most Recent Split Date: (:1)
Beta: 0.62
Market Capitalization: $4,299.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.66 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $6.14 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 8.63% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 10/22/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.60
Trailing 12 Months: 19.92
PEG Ratio: 2.39
Price Ratios
Price/Book: 2.50
Price/Cash Flow: 12.20
Price / Sales: 2.33
EPS Growth
vs. Year Ago Period: 3.23%
vs. Previous Quarter: 33.33%
Sales Growth
vs. Year Ago Period: -2.60%
vs. Previous Quarter: 5.58%
ROE
06/30/26 - 12.79
03/31/26 - 12.83
12/31/25 - 13.26
ROA
06/30/26 - 6.48
03/31/26 - 6.51
12/31/25 - 6.69
Current Ratio
06/30/26 - 3.73
03/31/26 - 3.75
12/31/25 - 3.32
Quick Ratio
06/30/26 - 2.41
03/31/26 - 2.38
12/31/25 - 2.23
Operating Margin
06/30/26 - 11.98
03/31/26 - 11.91
12/31/25 - 12.17
Net Margin
06/30/26 - 6.97
03/31/26 - 7.64
12/31/25 - 5.55
Pre-Tax Margin
06/30/26 - 7.40
03/31/26 - 8.55
12/31/25 - 6.76
Book Value
06/30/26 - 50.56
03/31/26 - 49.97
12/31/25 - 49.85
Inventory Turnover
06/30/26 - 5.03
03/31/26 - 5.12
12/31/25 - 5.19
Debt-to-Equity
06/30/26 - 0.75
03/31/26 - 0.77
12/31/25 - 0.69
Debt-to-Capital
06/30/26 - 42.86
03/31/26 - 43.46
12/31/25 - 41.00
 

Powered by Zacks Investment Research ©